These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15583731)

  • 21. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV treatment with pegylated interferon and ribavirin in patients with haemophilia and HIV/HCV co-infection.
    Denholm JT; Wright EJ; Street A; Sasadeusz JJ
    Haemophilia; 2009 Mar; 15(2):538-43. PubMed ID: 19187189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
    Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic modalities in hepatitis C: challenges and development.
    Moreno-Otero R
    J Viral Hepat; 2005 Jan; 12(1):10-9. PubMed ID: 15655043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
    McGovern B; Bica I
    Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
    [No Abstract]   [Full Text] [Related]  

  • 29. The natural history of chronic hepatitis C in haemophiliacs.
    Makris M; Preston FE; Rosendaal FR; Underwood JC; Rice KM; Triger DR
    Br J Haematol; 1996 Sep; 94(4):746-52. PubMed ID: 8826904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis in haemophilia.
    Makris M; Preston FE
    Blood Rev; 1993 Dec; 7(4):243-50. PubMed ID: 7510563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of hepatitis B and hepatitis C infection in haemophilia.
    Hanley JP; Dolan G; Day S; Skidmore SJ; Irving WL
    Br J Haematol; 1993 Nov; 85(3):611-2. PubMed ID: 7510994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods.
    Hanley JP; Jarvis LM; Andrews J; Dennis R; Lee R; Simmonds P; Piris J; Hayes P; Ludlam CA
    Br J Haematol; 1996 Jul; 94(1):159-65. PubMed ID: 8757528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral mononuclear cells of haemophiliacs with chronic liver disease are infected with replicating hepatitis C virus.
    Henin C; Makris M; Brown J; Peake IR; Preston EF
    Br J Haematol; 1994 May; 87(1):215-7. PubMed ID: 7947252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon therapy for Japanese hemophiliacs with chronic hepatitis C.
    Miura T; Meguro T; Takayama S; Yamada K
    Acta Paediatr Jpn; 1997 Oct; 39(5):556-8. PubMed ID: 9363652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of anti-interferon antibodies and breakthrough hepatitis during treatment for HCV infection in haemophiliacs.
    Hanley JP; Jarvis LM; Simmonds P; Ludlam CA
    Br J Haematol; 1996 Sep; 94(3):551-6. PubMed ID: 8790158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection.
    Tanaka Y; Hanada K; Hanabusa H; Kurbanov F; Gojobori T; Mizokami M
    J Gen Virol; 2007 Sep; 88(Pt 9):2513-2519. PubMed ID: 17698661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virological characteristics of HCV infection in Japanese haemophiliacs.
    Takayama S; Taki M; Meguro T; Nishikawa K; Shiraki K; Yamada K
    Haemophilia; 1997 Apr; 3(2):131-6. PubMed ID: 27214723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for haemophiliacs with hepatitis C cirrhosis.
    McCarthy M; Gane E; Pereira S; Tibbs CJ; Heaton N; Rela M; Hambley H; Williams R
    Gut; 1996 Dec; 39(6):870-5. PubMed ID: 9038673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non-virus inactivated factor VIII and IX concentrates.
    Watson HG; Ludlam CA; Rebus S; Zhang LQ; Peutherer JF; Simmonds P
    Br J Haematol; 1992 Apr; 80(4):514-8. PubMed ID: 1581236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications in HIV-infected and non-HIV-infected haemophiliacs and other patients after oral surgery.
    Scully C; Watt-Smith P; Dios RD; Giangrande PL
    Int J Oral Maxillofac Surg; 2002 Dec; 31(6):634-40. PubMed ID: 12521321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.